Price T Rowe Associates Inc Stoke Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

$867 Billion
Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 37,455 shares of STOK stock, worth $363,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,455

Previous 35,240 6.29%

Holding current value

$363,688

Previous $434,000 4.61%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$10.8 - $13.92 $23,922 - $30,832	2,215 Added 6.29%	37,455 $414,000
Q3 2024 Nov 14, 2024	BUY	$12.24 - $15.92 $2,374 - $3,088	194 Added 0.55%	35,240 $434,000
Q2 2024 Aug 14, 2024	BUY	$11.03 - $17.52 $39,873 - $63,334	3,615 Added 11.5%	35,046 $474,000
Q1 2024 May 15, 2024	BUY	$4.12 - $14.17 $6,765 - $23,267	1,642 Added 5.51%	31,431 $425,000
Q3 2023 Nov 14, 2023	SELL	$3.78 - $11.99 $1.24 Million - $3.95 Million	-329,133 Reduced 91.7%	29,789 $118,000
Q2 2023 Aug 14, 2023	SELL	$7.93 - $13.82 $149,710 - $260,907	-18,879 Reduced 5.0%	358,922 $3.82 Million
Q1 2023 May 15, 2023	SELL	$7.65 - $10.38 $132,390 - $179,636	-17,306 Reduced 4.38%	377,801 $3.15 Million
Q4 2022 Feb 14, 2023	SELL	$7.07 - $15.69 $121,858 - $270,432	-17,236 Reduced 4.18%	395,107 $3.65 Million
Q3 2022 Nov 14, 2022	SELL	$12.56 - $22.53 $54,987 - $98,636	-4,378 Reduced 1.05%	412,343 $5.3 Million
Q2 2022 Aug 15, 2022	SELL	$10.36 - $23.93 $73,991 - $170,908	-7,142 Reduced 1.68%	416,721 $5.51 Million
Q1 2022 May 16, 2022	SELL	$17.19 - $26.1 $247,260 - $375,422	-14,384 Reduced 3.28%	423,863 $8.92 Million
Q4 2021 Feb 14, 2022	BUY	$18.11 - $30.72 $1.82 Million - $3.09 Million	100,665 Added 29.82%	438,247 $10.5 Million
Q3 2021 Nov 15, 2021	SELL	$23.65 - $34.44 $1.18 Million - $1.72 Million	-49,841 Reduced 12.86%	337,582 $8.59 Million
Q2 2021 Aug 16, 2021	SELL	$30.53 - $41.09 $7.2 Million - $9.69 Million	-235,769 Reduced 37.83%	387,423 $13 Million
Q1 2021 May 17, 2021	SELL	$36.08 - $69.81 $4.56 Million - $8.83 Million	-126,434 Reduced 16.87%	623,192 $24.2 Million
Q4 2020 Feb 16, 2021	BUY	$33.62 - $61.93 $25.2 Million - $46.4 Million	749,626 New	749,626 $46.4 Million

Others Institutions Holding STOK

# of Institutions

135

Shares Held

57.3M

Call Options Held

5.7K

Put Options Held

24.4K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $383M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Stoke Therapeutics, Inc. Transaction History